CTRI/2017/12/010997CompletedPhase 1
The Effect of Probiotic VSL#3 and Lifestyle Intervention in Obese Children with Non Alcoholic Fatty Liver Disease(NAFLD):A Randomized Clinical Trial - NA
Babe Ke Ayurvedic Hospital VPO Daudhar0 sites106 target enrollmentStarted: TBDLast updated:
Trial Snapshot
- Phase
- Phase 1
- Status
- Completed
- Sponsor
- Enrollment
- 106
Study Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Interventional
Eligibility Criteria
Inclusion Criteria
- •Obese children in age group of 5-18 years old with NAFLD
- •(BMI) >=95th or 85th to 94th percentile with risk factors
Exclusion Criteria
- •Presence of liver disease due to hypothyroidism, wilson disease, viral hepatitis, cystic fibrosis, celiac disease, autoimmune hepatitis, drugs induced steatosis and gastrointestinal abnormalities.
Investigators
Similar Trials
Completed
Not Applicable
Probiotic Treatment in Juvenile Idiopathic Arthritis (JIA)Juvenile Idiopathic ArthritisNCT03092427Assistance Publique - Hôpitaux de Paris51
Completed
Phase 4
Effect of VSL#3 (Original De Simone Formulation) on Cognitive Function, Risk of Falls and Quality of Life in Patients With CirrhosisCognitive DysfunctionCirrhosisNCT01686698Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau40
Recruiting
Phase 2
Role of a probiotic, VSL#3, in the prevention of spontaneous bacterial peritonitisCTRI/2008/091/000079Dept of Gastroenterology250
Active, not recruiting
Not Applicable
To study the effect of probiotics in management of Poly cystic ovarian syndromeCTRI/2016/07/007086ICMR scholarship
Completed
Not Applicable
Probiotic VSL#3 for the Treatment of Gastrointestinal Symptoms Associated to FibromyalgiaGastrointestinal DiseaseFibromyalgiaNCT04256785Elena Pita Calandre110